Boston Scientific Corpora... (BSX)
NYSE: BSX
· Real-Time Price · USD
98.17
0.03 (0.03%)
At close: Sep 26, 2025, 3:59 PM
98.91
0.75%
After-hours: Sep 26, 2025, 07:48 PM EDT
Boston Scientific Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular Revenue | 3.35B | 3.08B | 2.94B | 2.73B | 2.64B | 2.44B | 2.29B | 2.19B | 2.24B | 2.11B | 2.13B | 2.06B | 2.07B | 1.9B | 1.27B | 1.2B | 1.26B | 1.13B | 1.01B | 1B | 834M | 1.03B | 1.2B | 1.01B | 1.03B | 972M | 971M | 908M | 965M | 933M | 883M | 857M | 889M | 871M | n/a | 2.69B | 1.79B | 877M | 835M | 797M | 812M | 773M | 779M | 731M | 738M | 705M | 728M | 689M | 742M | 708M |
| Cardiovascular Revenue Growth | +8.43% | +4.86% | +7.73% | +3.56% | +7.85% | +7.00% | +4.58% | -2.41% | +6.11% | -0.85% | +3.05% | -0.05% | +8.62% | +49.76% | +6.19% | -5.30% | +11.87% | +11.34% | +1.20% | +20.14% | -18.71% | -14.43% | +18.60% | -1.46% | +5.56% | +0.10% | +6.94% | -5.91% | +3.43% | +5.66% | +3.03% | -3.60% | +2.07% | n/a | -100.00% | +50.00% | +104.10% | +5.03% | +4.77% | -1.85% | +5.05% | -0.77% | +6.57% | -0.95% | +4.68% | -3.16% | +5.66% | -7.14% | +4.80% | n/a |
| MedSurg Revenue | 1.72B | 1.58B | 1.62B | 1.48B | 1.48B | 1.41B | 1.44B | 1.34B | 1.36B | 1.28B | 1.35B | 1.26B | 1.28B | 1.16B | 999M | 917M | 948M | 860M | 891M | 825M | 576M | 774M | 878M | 845M | 818M | 766M | 799M | 746M | 751M | 711M | 915M | 827M | 841M | 794M | n/a | 2.33B | 1.53B | 733M | 779M | 697M | 619M | 574M | 634M | 593M | 581M | 551M | 625M | 581M | 571M | 521M |
| MedSurg Revenue Growth | +8.81% | -2.59% | +9.47% | -0.27% | +5.03% | -2.01% | +7.46% | -1.40% | +6.25% | -5.54% | +7.54% | -1.41% | +9.79% | +16.52% | +8.94% | -3.27% | +10.23% | -3.48% | +8.00% | +43.23% | -25.58% | -11.85% | +3.91% | +3.30% | +6.79% | -4.13% | +7.10% | -0.67% | +5.63% | -22.30% | +10.64% | -1.66% | +5.92% | n/a | -100.00% | +51.96% | +109.00% | -5.91% | +11.76% | +12.60% | +7.84% | -9.46% | +6.91% | +2.07% | +5.44% | -11.84% | +7.57% | +1.75% | +9.60% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 1.84B | 1.7B | 1.67B | 1.62B | 1.65B | 1.6B | 1.51B | 1.43B | 1.49B | 1.39B | 1.32B | 1.24B | 1.31B | 1.25B | 1.33B | 1.21B | 1.28B | 1.17B | 1.18B | 1.1B | 885M | 1.05B | 1.95B | 1.58B | 1.15B | 1.09B | 1.1B | 1.02B | 1.1B | 1.07B | 924M | 907M | 947M | 978M | 1.98B | 990M | 1.04B |
| Non-Us Revenue Growth | +7.93% | +1.98% | +3.28% | -2.30% | +3.44% | +5.68% | +6.03% | -4.23% | +7.50% | +5.32% | +6.47% | -5.72% | +5.05% | -6.09% | +10.20% | -5.56% | +9.52% | -0.77% | +7.01% | +24.07% | -16.03% | -46.03% | +23.61% | +37.03% | +5.78% | -1.18% | +8.35% | -7.12% | +2.53% | +15.69% | +1.87% | -4.22% | -3.17% | -50.61% | +100.00% | -4.81% | n/a |
| United States Revenue | 2.04B | 2.96B | 2.89B | 2.59B | 2.47B | 2.26B | 2.21B | 2.1B | 2.11B | 2B | 1.99B | 1.93B | 1.93B | 1.78B | 1.8B | 1.73B | 1.8B | 1.59B | 1.53B | 1.56B | 1.12B | 1.49B | 1.71B | 373M | 1.48B | 1.4B | 1.46B | 1.38B | 1.39B | 1.31B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -31.01% | +2.32% | +11.57% | +5.15% | +9.21% | +2.03% | +5.43% | -0.52% | +5.34% | +0.81% | +2.74% | +0.05% | +8.72% | -1.17% | +4.23% | -4.11% | +13.49% | +3.39% | -1.67% | +39.53% | -24.92% | -12.72% | +357.37% | -74.76% | +5.35% | -3.84% | +6.11% | -1.36% | +6.41% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.72B | 1.6B | 1.61B | 1.56B | 1.45B | 1.36B | 1.38B | 1.24B | 1.35B | 1.22B | 1.16B | 1.12B | 1.17B | 1.06B | 1.15B | 1.07B | 1.12B | 1.02B | 1.03B | 984M | 798M | 978M | 1.09B | 1.01B | 968M | 869M | 946M | 868M | 891M | 852M | 882M | 797M | 812M | 791M | 828M | 768M | 779M | 716M | 777M | 729M | 700M | 668M |
| Selling, General, and Administrative Revenue Growth | +7.45% | -0.93% | +3.20% | +8.02% | +6.01% | -1.09% | +11.03% | -8.27% | +11.44% | +4.47% | +4.03% | -4.03% | +9.91% | -8.07% | +8.16% | -4.91% | +10.01% | -0.78% | +4.37% | +23.31% | -18.40% | -10.44% | +7.91% | +4.55% | +11.39% | -8.14% | +8.99% | -2.58% | +4.58% | -3.40% | +10.66% | -1.85% | +2.65% | -4.47% | +7.81% | -1.41% | +8.80% | -7.85% | +6.58% | +4.14% | +4.79% | n/a |
| Research and Development Revenue | 526M | 443M | 460M | 407M | 383M | 366M | 363M | 356M | 359M | 337M | 330M | 339M | 335M | 319M | 320M | 310M | 298M | 276M | 286M | 315M | 242M | 300M | 309M | 306M | 280M | 280M | 288M | 289M | 275M | 261M | 264M | 254M | 244M | 235M | 256M | 232M | 222M | 210M | 244M | 221M | 220M | 192M |
| Research and Development Revenue Growth | +18.74% | -3.70% | +13.02% | +6.27% | +4.64% | +0.83% | +1.97% | -0.84% | +6.53% | +2.12% | -2.65% | +1.19% | +5.02% | -0.31% | +3.23% | +4.03% | +7.97% | -3.50% | -9.21% | +30.17% | -19.33% | -2.91% | +0.98% | +9.29% | 0.00% | -2.78% | -0.35% | +5.09% | +5.36% | -1.14% | +3.94% | +4.10% | +3.83% | -8.20% | +10.34% | +4.50% | +5.71% | -13.93% | +10.41% | +0.45% | +14.58% | n/a |